P2 3L+ Registration Exp SCLC.
Research payments
$417,179
Through program year 2024, $417,179 in research payments was reported against P2 3L+ Registration Exp SCLC., across 52 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $160,975 | 31 |
| 2023 | Research | $256,203 | 21 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Suresh Ramalingam Atlanta, GA Named on 6 payments
- Jacob Sands Boston, MA Named on 5 payments
- Jeffrey Clarke Durham, NC Named on 4 payments
- Melissa Johnson Nashville, TN Named on 4 payments
- Mohammed Almubarak Morgantown, WV Named on 4 payments
- William Petty Winston Salem, NC Named on 3 payments
- Shirish Gadgeel Detroit, MI Named on 3 payments
- Taofeek Owonikoko Baltimore, MD Named on 3 payments
- Timothy Burns Pittsburgh, PA Named on 3 payments
- Jean Bustamante New York, NY Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.